With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Ongoing policy issues in the U.S., including the Inflation Reduction Act and recent proposals under President Donald Trump’s administration, have wide ranging implications for the global ...

Good morning. Biotech was not faring well yesterday, after we got the news that Vinay Prasad was chosen to be the next ...

About Factor Bioscience Founded in 2011, Factor Bioscience is a biotechnology company focused on using its patented gene-editing platform to develop life-saving cell and gene therapies. Factor ...

The Toshiba/NSTA ExploraVision competition is designed to inspire students to develop the skills emphasized in the Next Generation Science Standards, including problem-solving, critical-thinking and ...

A whirlwind of sessions, keynotes, fireside chats, posters, and exhibitors ... LeMieux: What are some of the hot topics for this year? Siu: I will highlight the clinical trials that are being ...

DFC has agreed to provide a long-term loan of up to USD 20 million to the company to help finance this project, the biotechnology firm said in a regulatory filing. DFC's financing will enable Panacea ...

McCall, along with her colleague Jordin Lane, Ph.D., in the School of Public Health, was awarded the 2025 Best Research for their poster presentation on Engaging ... To learn more about UAB ...

Currently, Phase 3 clinical trials of the vaccine, developed jointly by ICMR and Panacea Biotech, are underway and have shown promising results thus far. If the ongoing Phase 3 trials are successful, ...